SCHEMBL12825901

SCHEMBL12825901

COc1ccccc1CNc1ncc2c(n1)N(C1CCCC1)CC(C)(C)C(=O)N2C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLK1 P53350 14/20 0.47
BRD4 O60885 1/20 0.47
BRDT Q58F21 1/20 0.47
PDE9A O76083 2/20 0.45
SELP P16109 2/20 0.45
TYRO3 Q06418 2/20 0.45
CHEK1 O14757 1/20 0.45
IKBKB O14920 1/20 0.45
AURKA O14965 1/20 0.45
PAK4 O96013 1/20 0.45
CHEK2 O96017 1/20 0.45
ABL1 P00519 1/20 0.45
EGFR P00533 1/20 0.45
INSR P06213 1/20 0.45
LCK P06239 1/20 0.45
FGFR1 P11362 1/20 0.45
CSNK2A2 P19784 1/20 0.45
CCNA2 P20248 1/20 0.45
CDK2 P24941 1/20 0.45
MAPK1 P28482 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2323716 0.93 PLK1 (0.47) PLK1BRD4BRDTSELPTYRO3
SCHEMBL2396454 0.87 PLK1 (0.57) PLK1BRD4BRDTTTK
SCHEMBL2396321 0.85 PLK1 (0.46) PLK1BRD4BRDTPDE9ATTK
SCHEMBL524087 0.84 PLK1 (0.46) PLK1BRD4BRDTTTK
SCHEMBL523913 0.84 PLK1 (0.46) PLK1BRD4BRDTTTK
SCHEMBL2322536 0.83 PLK1 (0.45) PLK1BRD4BRDTTTK
SCHEMBL2326641 0.82 PLK1 (0.48) PLK1BRD4BRDTTYRO3IKBKB
SCHEMBL2321921 0.82 PLK1 (0.45) PLK1BRD4BRDTTYRO3TTK
SCHEMBL2324091 0.81 PLK1 (0.45) PLK1BRD4BRDTTTK
SCHEMBL2321132 0.81 PLK1 (0.44) PLK1BRD4BRDTTYRO3TTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011036566-A1 METHODS FOR PREPARING PYRIMIDINE DERIVATIVES USEFUL AS PROTEIN KINASE INHIBITORS VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-03-31 WO disclosed